N epsilon-(hexanoyl) lysine, a new oxidative stress marker, is increased in metabolic syndrome, but not in obstructive sleep apnea

American Journal of the Medical Sciences

Volumn 338, Issue 2, 2009, Pages 127-133

  Tokuda, Fumie ^a   Sando, Yoshichika ^b   Matsui, Hiroki ^a   Yokoyama, Tomoyuki ^a  

^a GUNMA UNIVERSITY   (Japan)

^b Koyagi Clinic   (Japan)

Author keywords

Antioxidant status; Metabolic syndrome; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; GLUCOSE; INSULIN; N EPSILON(HEXANOYL)LYSINE; UNCLASSIFIED DRUG;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; SLEEP APNEA SYNDROME; URINE LEVEL;

EID: 69349104614     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181a478e5     Document Type: Article

References (32)

1. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716
2. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689
3. Smith SR. Importance of diagnosing and treating the metabolic syndrome in reducing cardiovascular risk. Obesity (Silver Spring) 2006;14(suppl 3):128S-134S.
4. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004;24:816-823
5. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000;87:840-844
6. Harman SM, Liang L, Tsitouras PD, et al. Urinary excretion of three nucleic acid oxidation adducts and isoprostane F(2)alpha measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers. Free Radic Biol Med 2003;35:1301-1309
7. Steinberg D, Witztum JL. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation 2002;105:2107-2111
8. Redon J, Oliva MR, Tormos C, et al. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 2003;41:1096-1101
9. Demirbag R, Yilmaz R, Kocyigit A. Relationship between DNA damage, total antioxidant capacity and coronary artery disease. Mutat Res 2005;570:197-203.
10. Mallat Z, Philip I, Lebret M, et al. Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 1998;97:1536-1539
11. Demirbag R, Yilmaz R, Gur M, et al. DNA damage in metabolic syndrome and its association with antioxidative and oxidative measurements. Int J Clin Pract 2006;60:1187-1193
12. Ford ES, Mokdad AH, Giles WH, et al. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 2003;52:2346-2352
13. Fujita K, Nishizawa H, Funahashi T, et al. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J 2006;70:1437-1442
14. Yamauchi M, Nakano H, Maekawa J, et al. Oxidative stress in obstructive sleep apnea. Chest 2005;127:1674-1679
15. Barcelo A, Miralles C, Barbe F, et al. Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 2000;16:644-647
16. Christou K, Moulas AN, Pastaka C, et al. Antioxidant capacity in obstructive sleep apnea patients. Sleep Med 2003;4:225-228
17. Svatikova A, Wolk R, Lerman LO, et al. Oxidative stress in obstructive sleep apnoea. Eur Heart J 2005;26:2435-2439
18. Kato Y, Mori Y, Makino Y, et al. Formation of Nepsilon-(hexanonyl) lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification. J Biol Chem 1999;274:20406-20414
19. Abdilla N, Tormo MC, Fabia MJ, et al. Impact of the components of metabolic syndrome on oxidative stress and enzymatic antioxidant activity in essential hypertension. J Hum Hypertens 2007;21:68-75.
20. Kato Y, Yoshida A, Naito M, et al. Identification and quantification of N(epsilon)-(Hexanoyl)lysine in human urine by liquid chromatography/tandem mass spectrometry. Free Radic Biol Med 2004;37:1864-1874.
21. Kendall DM, Harmel AP. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance. Am J Manag Care 2002;8(suppl 20):S635-S653; quiz S654-S657.
22. Komosinska-Vassev K, Olczyk K, Olczyk P, et al. Effects of metabolic control and vascular complications on indices of oxidative stress in type 2 diabetic patients. Diabetes Res Clin Pract 2005;68:207-216
23. Kaneko T, Tahara S, Matsuo M. Non-linear accumulation of 8-hydroxy-2′-deoxyguanosine, a marker of oxidized DNA damage, during aging. Mutat Res 1996;316:277-285
24. Loft S, Vistisen K, Ewertz M, et al. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis 1992;13:2241-2247
25. Dandona P, Thusu K, Cook S, et al. Oxidative damage to DNA in diabetes mellitus. Lancet 1996;347:444-445
26. Mizoue T, Kasai H, Kubo T, et al. Leanness, smoking, and enhanced oxidative DNA damage. Cancer Epidemiol Biomarkers Prev 2006;15:582-585
27. Higashi Y, Sasaki S, Nakagawa K, et al. Low body mass index is a risk factor for impaired endothelium-dependent vasodilation in humans: role of nitric oxide and oxidative stress. J Am Coll Cardiol 2003;42:256-263
28. Zawadzka-Bartczak E. Activities of red blood cell anti-oxidative enzymes (SOD, GPx) and total anti-oxidative capacity of serum (TAS) in men with coronary atherosclerosis and in healthy pilots. Med Sci Monit 2005;11:CR440-4.
29. Leeuwenburgh C, Heinecke JW. Oxidative stress and antioxidants in exercise. Curr Med Chem 2001;8:829-838
30. Leeuwenburgh C, Hollander J, Leichtweis S, et al. Adaptations of glutathione antioxidant system to endurance training are tissue and muscle fiber specific. Am J Physiol 1997;272(1 Pt 2):R363-R369.
31. Powers SK, Criswell D, Lawler J, et al. Rigorous exercise training increases superoxide dismutase activity in ventricular myocardium. Am J Physiol 1993;265(6 Pt 2):H2094-H2098.
32. Powers SK, Criswell D, Lawler J, et al. Influence of exercise and fiber type on antioxidant enzyme activity in rat skeletal muscle. Am J Physiol 1994;266(2 Pt 2):R375-R380.